Trial Profile
Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2022
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Paracetamol
- Indications Coronary artery disease; Myocardial infarction
- Focus Pharmacokinetics
- Acronyms The GASTRIM study
- 08 Feb 2022 Status changed from recruiting to completed.
- 24 Jan 2017 Planned End Date changed from 1 Oct 2015 to 8 Jun 2017.
- 24 Jan 2017 Planned primary completion date changed from 1 Oct 2015 to 8 Jun 2017.